Application of neojusticidin B in preparation of blood fat reducing drug

A blood lipid-lowering drug, the technology of Jucetidine, which is applied in the field of medicine, can solve the problems of bleeding, drug simultaneous treatment of hyperlipidemia and thrombosis, and significant differences in the efficacy of individual patients, so as to accelerate lipid clearance and reduce lipid absorption and the effect of operation

Pending Publication Date: 2021-12-07
HUBEI UNIV OF CHINESE MEDICINE
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

With the increase of statistical cases of the above drugs, more and more patients have experienced many adverse reactions such as significant individual curative effect differences, drug resistance and gastrointestinal bleeding.
[0005] At present,

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of neojusticidin B in preparation of blood fat reducing drug
  • Application of neojusticidin B in preparation of blood fat reducing drug
  • Application of neojusticidin B in preparation of blood fat reducing drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Example 1: Preparation B lipid New kitsunenomago given

[0034] 1 Materials

[0035] 1.1 acanthus herbs

[0036] Acanthaceae autumn harvest herbs in 2019 in Wuhan City, Jiangxia District, and by Professor Wu Zhen Hubei University of Chinese Medicine identified as Acanthaceae Acanthaceae acanthus plants.

[0037] 1.2 Reagents

[0038] Ethanol, methanol, analytical grade, commercially available from Sinopharm Chemical Reagent Co., Ltd.; acetonitrile HPLC grade, available from Merck Chemicals Ltd; D101 macroporous resin, available from New Materials Technology Co. blue dawn.

[0039] 2 Methods

[0040] 2.1 New Acanthaceae aliphatic predetermined Preparation B

[0041] Acanthaceae take medicine 30kg, pulverizing, screening through a No. 2, 80% ethanol percolation percolate was concentrated under reduced pressure until no alcohol taste, extracted twice with ethyl acetate and the combined ethyl acetate solution under reduced pressure to recover the solvent, the residue 30% ethano...

Embodiment 2

[0044] Example 2: New kitsunenomago lipid lowering efficacy studies given B

[0045] 1 Materials

[0046] 1.1 Animals

[0047] SD rats were purchased from Experimental Animal Center of China Three Gorges University.

[0048] 1.2 Reagents

[0049] Serum total cholesterol kit, triglycerides kits, biochemical reagents were purchased from Eli Reiter Wuhan Biological Technology Co., Ltd.; high-fat diet was purchased from Hubei Province CDC; other reagents were analytical grade purchased from Sinopharm Chemical reagent Co., Ltd.

[0050] 2 Methods

[0051] 2.1 hyperlipidemia modeling

[0052] Take 30 SD rats, adaptive 7D rearing, blood total cholesterol, triglycerides, take the tail. The level of total cholesterol, use stratified random sampling packets rats, each rat appropriately adjusted total cholesterol and balanced distribution of initial body weight. After the start of the test, in addition to the basal diet control group, other groups were fed with high fat diet, continuous 30d....

Embodiment 3

[0063] Example 3: B - lipid kitsunenomago new antithrombotic efficacy of a given

[0064] 1 Materials

[0065] 1.1 Animals

[0066] SD rats were purchased from Experimental Animal Center of China Three Gorges University.

[0067] 1.2 Reagents

[0068] Hematoxylin dye, eosin dye available from Biological Technology Co., Xavier; sodium pentobarbital was purchased from Merck Chemicals Ltd.; the IAM iodoacetamide, Triethylammonium bicarbonate buffer (TEAB) were purchased from Sigma-Aldrich (Shanghai ) Ltd.; ModifiedTrypsin protease (mass spectroscopy grade) was purchased from PROMEGA Corporation; acetonitrile (mass spectroscopy grade), methanol (stage mass spectrometry), formic acid (mass spectroscopy grade), TMT 10Plex, Protein Ladder (prestained), ProteaseInhibitor Cocktail (protease inhibitor ), PierceTM BCA protein Assay kit, NUPAGE 10% BTGEL 1.0MM 12W, BreakerTM TCEP Solution (TCEP) was purchased from Thermo Fisher Scientific Ltd; BCA protein Assay kit was purchased from Eli Reit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an application of neojusticidin B in preparation of a blood fat reducing drug. The neojusticidin B has the effects of reducing lipid absorption and operation and accelerating lipid clearance by up-regulating the expression of apolipoprotein A-II and apolipoprotein C-II and down-regulating the expression of glycoprotein IIIb; and the anticoagulant effect is generated by down-regulating the expression of a blood coagulation factor X, the anti-platelet aggregation effect is generated by down-regulating the expression of fibrinogen, and the antithrombotic effect is realized through anticoagulation and anti-platelet aggregation. The neojusticidin B is novel in blood fat reducing action mechanism, provides a new scheme for treatment of hyperlipidemia diseases, and particularly provides a new scheme for clinical treatment of thrombotic diseases further caused by atherosclerosis caused by hyperlipidemia.

Description

Technical field [0001] The present invention relates to the use of new set B kitsunenomago lipid in the manufacture of a medicament for hypolipidemic, belonging to the field of medical technology. Background technique [0002] With an aging population, changing lifestyles and habits, lipid metabolism disorders has increasingly become a major global health problem, it has become an important cause of death in the world. Epidemiological display lipid levels in Chinese population increased year by year, a significant increase in the prevalence of dyslipidemia, become a heavy burden on the basic medical insurance for urban residents. Elevated serum cholesterol levels of the population will result in 2010 - cardiovascular disease events of 2030 increased by about 9.2 million. Children and adolescents prevalence of hypercholesterolemia was significantly higher, indicating that the burden of future Chinese adult prevalence of dyslipidemia and related diseases will continue to increase. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/365A61P7/02A61P3/06A61P9/10A61K36/19
CPCA61K31/365A61P7/02A61P3/06A61P9/10A61K36/19
Inventor 刘博吴和珍杨艳芳陆毅洪宗超艾中柱吴松涛
Owner HUBEI UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap